Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 100 of 275 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/13
End: 06/30/14
Due: 06/30/15
Phase: N/A
Priority: Normal
Start: 10/31/16
End: 06/30/17
Due: 06/30/18
Phase: N/A
Priority: Normal
Start: 09/30/10
End: 03/31/15
Due: 03/31/16
Phase: N/A
Priority: Normal
Start: 04/30/10
End: 04/30/13
Due: 04/30/14
Phase: N/A
Priority: Normal
Start: 03/31/16
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/26/20
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 04/05/25
End: 12/31/29
Due: 12/31/30
Phase: N/A
Priority: Normal
Start: 10/31/15
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/12/15
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 08/31/16
End: 10/31/17
Due: 10/31/18
Phase: N/A
Priority: Normal
Start: 04/08/25
End: 04/01/26
Due: 04/01/27
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 06/30/13
Due: 06/30/14
Recombinant Human Thrombopoietin (rhTPO) in Management of Immune Thrombocytopenia (ITP) in Pregnancy
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 04/30/17
Due: 04/30/18
Phase: N/A
Priority: Normal
Start: 07/01/22
End: 08/25/24
Due: 08/25/25
Phase: N/A
Priority: Normal
Start: 03/14/23
End: 04/01/26
Due: 04/01/27
Phase: N/A
Priority: Normal
Start: 09/16/22
End: 05/31/25
Due: 05/31/26
Phase: N/A
Priority: Normal
Start: 11/01/19
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 05/16/22
End: 12/01/25
Due: 12/01/26
Phase: N/A
Priority: Normal
Start: 10/20/18
End: 05/31/19
Due: 05/31/20
Phase: N/A
Priority: Normal
Start: 06/30/14
End: 02/28/19
Due: 02/28/20
Phase: N/A
Priority: Normal
Start: 09/30/14
End: 08/31/17
Due: 08/31/18
Phase: N/A
Priority: Normal
Start: 07/01/18
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 06/30/16
End: 03/31/17
Due: 03/31/18
Phase: N/A
Priority: Normal
Start: 08/20/23
End: 02/01/25
Due: 02/01/26
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 12/31/18
Due: 12/31/19